NCT00837967View on ClinicalTrials.gov

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Asthma
Interventions
DRUG

Symbicort Turbuhaler

160/4.5μg for 3 days

DRUG

Terbutaline Turbuhaler

0.4 mg for 3 days

Trial Locations (2)

Unknown

Research Site, Ibaraki

Research Site, Tokyo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY